1Burgener-Kairuz.P.,J.P.Zuber,P.Jaunin,et al.Rapid detection and identification of Candida albicans and Torulopsis(Candida) glabrata in Clinical specimens by species-speicific nested PCR amplification of a cytochrome P-450 lanosterol-α-demethylase(LIAl)gene fragment[J].J Clin Microbiol 1994,32:1902-7
2Homayom Sanati, Paul Belanger, Rutilio Fratti, et al. A new triazole, Voriconazole(UK- 109, 496), blocks sterol biosynthesis in Candida albicens and Candida krudei[ J ]. Antimicrob Agents Chemother 1997, 41 (11): 2496-6.
3F. Marco, M. A. Pfaller, S. Mesaer, et al. In vitro activities of voriconaole (UK- 109, 496) and four other antifungal agents against 394 clinical isolates of Candida spp[J]. Antimicrob Agents Chemother 1998, 42(1): 161-3.
4Nicholas C. Karyotakis, M. Cecilia Dignani, Elias J. Anaissie.SCH 51048, anew antifungal triazole active against hematogenous Candida krusei infections in neutropenic mice[ J ]. Antimicrob Agents Chemother 1995, 39 (3): 775-7.
5ER-30346[J].Drugs Fut, 1998, 23 (1): 89.
6ER-30346[J]. Drugs Fut, 1999, 24 (1): 86-88.
7D0870[J].Drugs Fut,,1998, 23 (5): 543-544.
8D0870[J].Drugs Fut, 1997, 225 (5): 563-554.
9Syn2869[J]. Drugs Fut, 1999, 24 (1): 30-37.
10J. R. Graybill, R. Bocanegra, M. Luther, et al. Treatment of murine Candida krusei or Gandida glabrata infection with L-743, 872[J].Antimicrob Agents chemother, 1997,41(9):1937-9.
